Physician Profile
Back to directory
Martha Arellano MD
Hematologist
CAR T-Cell TherapyLeukemiaMyelodysplastic SyndromeAcute Leukemia
Contact Information
Verified Physician Access
Phone numbers and email addresses are available to physicians verified by Winship Cancer Institute.
Treatment Locations
Emory University Hospital
Clinical Trials
Phase I/IISTUDY00008442
A Phase 1/2 Study to Evaluate the Safety and Efficacy of AZD0486 in Adolescent and Adult Participants With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia
View
Phase ISTUDY00006983
Phase 1 Study of Venetoclax/Azacitidine or Venetoclax in Combination With Ziftomenib or Standard Induction Cytarabine/Daunorubicin (7+3) Chemotherapy in Combination With Ziftomenib for the Treatment of Patients With Acute Myeloid Leukemia
View
Phase ISTUDY00007939
Phase 1 Study to Determine the Safety and Tolerability of Ziftomenib Combinations for the Treatment of KMT2A-rearranged or NPM1-mutant Relapsed/Refractory Acute Myeloid Leukemia
View
Phase I/IIIRB00116162
A Phase 1/2, Open-label, Dose-Escalation and Dose-Expansion Cohort Study of SNDX-5613 in Patients With Relapsed/Refractory Leukemias, Including Those Harboring an MLL/KMT2A Gene Rearrangement or Nucleophosmin 1 (NPM1) Mutation
View
